Yang H - Search Results

1

[Retracted] MicroRNA‑133a acts as a tumour suppressor in breast cancer through targeting LASP1.

Sui Y, Zhang X, Yang H, Wei W, Wang M. Sui Y, et al. Among authors: yang h. Oncol Rep. 2022 Jul;48(1):119. doi: 10.3892/or.2022.8330. Epub 2022 May 18. Oncol Rep. 2022. PMID: 35583001 Free PMC article.

2

Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.

Yan Y, Han J, Li Z, Yang H, Sui Y, Wang M. Yan Y, et al. Among authors: yang h. Mol Med Rep. 2016 Jun;13(6):5125-31. doi: 10.3892/mmr.2016.5190. Epub 2016 Apr 26. Mol Med Rep. 2016. PMID: 27122348 Free PMC article.

3

MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.

Sui Y, Zhang X, Yang H, Wei W, Wang M. Sui Y, et al. Among authors: yang h. Oncol Rep. 2018 Feb;39(2):473-482. doi: 10.3892/or.2017.6114. Epub 2017 Nov 27. Oncol Rep. 2018. Retraction in: Oncol Rep. 2022 Jul;48(1):119. doi: 10.3892/or.2022.8330 PMID: 29207145 Free PMC article. Retracted.

4

Endostar continuous intravenous infusion combined with S-1 and oxaliplatin chemotherapy could be effective in treating liver metastasis from gastric cancer.

Yang H, Sui Y, Guo X, Tan X, Li Y, Wang M. Yang H, et al. J Cancer Res Ther. 2018 Dec;14(Supplement):S1148-S1151. doi: 10.4103/0973-1482.204880. J Cancer Res Ther. 2018. PMID: 30539861 Free article. Clinical Trial.

5

Hepatoid adenocarcinoma of the lung with PD-L1 expression and the response to anti-PD-1 therapy: a case report.

Li Y, Liu L, Wang D, Tan X, Sui Y, Yang H. Li Y, et al. Among authors: yang h. Front Oncol. 2023 Nov 23;13:1257931. doi: 10.3389/fonc.2023.1257931. eCollection 2023. Front Oncol. 2023. PMID: 38074660 Free PMC article.

6

lncRNA TINCR facilities bladder cancer progression via regulating miR‑7 and mTOR.

Xu G, Yang H, Liu M, Niu J, Chen W, Tan X, Sun L. Xu G, et al. Among authors: yang h. Mol Med Rep. 2020 Nov;22(5):4243-4253. doi: 10.3892/mmr.2020.11530. Epub 2020 Sep 22. Mol Med Rep. 2020. PMID: 33000269 Free PMC article.

7

Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma.

Ma YT, Li Y, Yan L, Hua F, Wang DG, Xu GY, Yang HL, Xue YJ, Qin YJ, Sha D, Ning H, Zhao MQ, Yao ZG. Ma YT, et al. Among authors: yang hl. Pathol Oncol Res. 2023 Jan 30;29:1610989. doi: 10.3389/pore.2023.1610989. eCollection 2023. Pathol Oncol Res. 2023. PMID: 36794259 Free PMC article.

8

Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma.

Ma YT, Yang HL, Yan L, Hua F, Wang DG, Xu GY, Li Y, Xue YJ, Qin YJ, Sha D, Ning H, Zhao MQ, Yao ZG. Ma YT, et al. Among authors: yang hl. Pathol Oncol Res. 2022 Oct 21;28:1610638. doi: 10.3389/pore.2022.1610638. eCollection 2022. Pathol Oncol Res. 2022. PMID: 36338826 Free PMC article.

9

A prognostic model for predicting progression-free survival in patients with advanced non-small cell lung cancer after image-guided microwave ablation plus chemotherapy.

Kong F, Yang H, Wang Q, Wei Z, Ye X. Kong F, et al. Among authors: yang h. Eur Radiol. 2023 Nov;33(11):7438-7449. doi: 10.1007/s00330-023-09804-9. Epub 2023 Jun 15. Eur Radiol. 2023. PMID: 37318606 Free PMC article. Clinical Trial.

10

Recent Advances in Radical Coupling Reactions Directly Involving Bicyclo[1.1.1]pentane (BCP).

Jin J, Yang H, Xiang H, Lu Y, Ye Y. Jin J, et al. Among authors: yang h. Top Curr Chem (Cham). 2025 Jan 18;383(1):6. doi: 10.1007/s41061-025-00490-3. Top Curr Chem (Cham). 2025. PMID: 39826019 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,467 results

Search Page

Filters